等待开盘 09-11 09:30:00 美东时间
-0.510
-1.57%
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Cantor Fitzgerald raised the price target for Salesforce Inc (NYSE:CRM) from $250 to $300. Cantor Fitzgerald a...
09-02 20:27
今日重点评级关注:杰富瑞:维持拜玛林制药"买入"评级,目标价从104美元升至105美元;RBC Capital:维持Shift4 Payments"跑赢大市"评级,目标价从63美元升至67美元
09-01 08:37
RBC Capital analyst Daniel R. Perlin maintains Toast (NYSE:TOST) with a Sector Perform and raises the price target from $36 to $44.
08-31 21:58
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders will search for circumstances when the market estimation of an option diverges heavily...
08-29 01:35
As the month of August 2026 comes to a close, the broader stock market has exhibited a mix of late-summer consolidation and selective sector rotation. Investors continue to digest shifting macroeconom...
08-29 00:30
Mondelēz International (MDLZ) plans to play into the high-protein trend with the introduction of a new Clif High Protein bar, crafted with quality ingredients like rolled oats, creamy nut butters, alm...
08-25 20:13
The Marzetti Company’s fiscal Q4 2026 earnings call covered $465 million in sales, margin expansion, Bachan’s growth and its fiscal 2027 outlook.
08-25 20:00
On CNBC’s “Halftime Report Final Trades,” Jenny Van Leeuwen Harrington, chief executive officer of Gilman Hill Asset Management, LLC, picked Microchip Technology (NASDAQ:MCHPP). Amy Raskin, chief investment officer at Chevy Chase Trust, named Cognex Corporation (NASDAQ:CGNX) as her final trade. Lend...
08-24 20:15
Adyen press release (ADYEY): 1H Revenue of €1,302.9 million, up 19% year-on-year (YoY) (21% on a constant currency basis). Processed volume was €803.8 billion, up 24% YoY. EBITDA was €641.5 million, w...
08-13 15:56
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从49美元升至56美元;韦德布什:维持Zura Bio"跑赢大市"评级,目标价从15美元升至22美元
08-13 11:44